Navigation Links
Stroke-preventing technology demonstrated in JoVE
Date:2/28/2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.

Researchers from Atritech, now part of Boston Scientific, developed the WATCHMAN device, a small mesh umbrella that can be inserted into part of the heart cavity to prevent the formation of blood clots that cause strokes.

Currently, the anti-coagulant drug warfarin is used to prevent strokes, but the drug comes with other risks.

Warfarin has a lot of side-effects. One major side-effect is the bleeding risk, said paper author Dr. Sven Mobius-Winkler. Therefore, only 50 percent of the patients who should take Warfarin actually take it.

The WATCHMAN device gives patients another option. It has already been approved for use in the European Union and Australia, and secured investigational approval from the FDA in 2009.

To help train doctors how to use the device, doctors from the University of Leipzig Heart Center in Germany are publishing the full WATCHMAN placement procedure in the Journal of Visualized Experiments (JoVE), the worlds first and only peer-reviewed, PubMed indexed, science and medicine video journal.

Intervention and closure of the left atrial appendage is a complex procedure, said Dr. Mobius- Winkler. For inexperienced physicians, it is hard to learn this procedure and therefore the video can help by doing step-by-step the implantation.

The WATCHMAN device will give patients with atrial fibrillation another option rather than anti-coagulant drugs, said JoVE Editor Dr. Robert Dolan. This article demonstrates the implantation of the device and will help clinicians gain expertise with the procedure, helping many of the patients who are unable or unwilling to take warfarin.


'/>"/>

Contact: Katherine Scott
katherine.scott@jove.com
617-820-1817
The Journal of Visualized Experiments
Source:Eurekalert  

Related medicine news :

1. Development of social technology to improve the quality of life of intellectually disabled people
2. New technology to tackle treatment-resistant cancers
3. Research finds newer radiation therapy technology improves patients quality of life
4. American College of Physicians, CECity launch new quality improvement technology platform
5. Patients at risk of knee joint complications when new technology is used
6. Notre Dame, Purdue and GE Healthcare partner on new CT technology
7. Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU
8. Combined arterial imaging technology reveals both structural and metabolic details
9. Health Information Technology and Patient Safety - IOM report releases Nov. 10
10. Modern Technology Reveals Clues From Egyptian Mummy
11. Federal government releases environmental, health, and safety research strategy for nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stroke-preventing technology demonstrated in JoVE
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)...   ZirMed Inc ., a recognized leader in cloud-based ... has been ranked #1 by its users for the seventh ... User Survey. ZirMed was recognized as the top-ranked end-to-end revenue ... centers over 200 beds and holds one of the longest ... history. ...
(Date:9/12/2017)... Sept. 12, 2017  Consumer reviews on the independent review site ... the number one company for hearing aids, ranking it higher than ... brands. ... #1 by Consumers For Hearing Aids ... Hearing is an online store that provides high performance, state-of-the-art, German-engineered ...
Breaking Medicine Technology: